Bioengineered, Sirolimus-Eluting Stent Found ‘Safe,’ and ‘Effective’
November 14, 2011|Cardiology
Author and Disclosure Information
FROM TRANSCATHETER CARDIOVASCULAR THERAPEUTICS 2011
Dr. Haude reported that he receives research or grant support from OrbusNeich and Biotronik and consultant fees and honoraria from Medtronic, Abbott Vascular, and Volcano Corp. Dr. Hodgson reported that he receives research or grant support from Boston Scientific, Volcano Corp., and St. Jude Medical, and that he is a consultant to, is a speaker for, or receives honoraria from Volcano Corp. The trial was sponsored by OrbusNeich.
